Integrated personalized diabetes management goes Europe: A multi-disciplinary approach to innovating type 2 diabetes care in Europe

Allan Jones*, Jakob Eyvind Bardram, Per Bækgaard, Claus Lundgaard Cramer-Petersen, Timothy Skinner, Karsten Vrangbæk, Laila Starr, Kirsten Nørgaard, Nanna Lind, Merete Bechmann Christensen, Charlotte Glümer, Rui Wang-Sattler, Michael Laxy, Erik Brander, Lutz Heinemann, Tim Heise, Freimut Schliess, Katharina Ladewig, Dagmar Kownatka

*Corresponding author for this work

Research output: Contribution to journalReviewResearchpeer-review

3 Downloads (Pure)

Abstract

Type 2 diabetes mellitus represents a multi-dimensional challenge for European and global societies alike. Building on an iterative six-step disease management process that leverages feedback loops and utilizes commodity digital tools, the PDM-ProValue study program demonstrated that integrated personalized diabetes management, or iPDM, can improve the standard of care for persons living with diabetes in a sustainable way. The novel “iPDM Goes Europe” consortium strives to advance iPDM adoption by (1) implementing the concept in a value-based healthcare setting for the treatment of persons living with type 2 diabetes, (2) providing tools to assess the patient's physical and mental health status, and (3) exploring new avenues to take advantage of emerging big data resources.

Original languageEnglish
JournalPrimary Care Diabetes
Number of pages5
ISSN1751-9918
DOIs
Publication statusAccepted/In press - 2020

Keywords

  • Artificial intelligence
  • Delivery of health care, integrated
  • Diabetes mellitus, type 2
  • Patient reported outcome measures
  • Value-based health insurance

Fingerprint Dive into the research topics of 'Integrated personalized diabetes management goes Europe: A multi-disciplinary approach to innovating type 2 diabetes care in Europe'. Together they form a unique fingerprint.

Cite this